DESIGN OF THE SILENT CEREBRAL INFARCT TRANSFUSION (SIT) TRIAL

BACKGROUND: Silent cerebral infarct (SCI) is the most common cause of serious neurological disease in sickle cell anemia (SCA), affecting approximately 22% of children. The goal of this trial is to determine whether blood transfusion therapy will reduce further neurological morbidity in children wit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pediatr Hematol Oncol
Egile Nagusiak: Casella, James F., King, Allison A., Barton, Bruce, White, Desiree A., Noetzel, Michael J., Ichord, Rebecca N., Terrill, Cindy, Hirtz, Deborah, McKinstry, Robert C., Strouse, John J., Howard, Thomas H., Coates, Thomas D., Minniti, Caterina P, Campbell, Andrew D., Vendt, Bruce A., Lehmann, Harold, DeBaun, Michael R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572477/
https://ncbi.nlm.nih.gov/pubmed/20201689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/08880010903360367
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak